AUP.TO
Aurinia Pharmaceuticals Inc
Price:  
16.76 
CAD
Volume:  
137,920.00
Canada | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

AUP.TO Fair Value

-132.16 %
Upside

As of 2024-02-26, the Fair Value of Aurinia Pharmaceuticals Inc (AUP.TO) is -5.39 CAD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 16.76 CAD, the upside of Aurinia Pharmaceuticals Inc is -132.16%.

Note: valuation result may not be accurate due to the company's negative EPS.

16.76 CAD
Stock Price
-5.39 CAD
Fair Price
FAIR VALUE CALCULATION

AUP.TO Fair Value

Peter Lynch's formula is:

AUP.TO Fair Value
= Earnings Growth Rate x TTM EPS
AUP.TO Fair Value
= 5.00 x -0.80
AUP.TO Fair Value
= -5.39

The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.

Historical Earnings
- - - - - 5Y Avg
Net income - - - - - -
YoY growth - - - - - -%

AUP.TO Fair Value - Key Data

Market Cap (mil) 2,147.89
P/E
Forward P/E
EPS -0.80
Avg earnings growth rate -%
TTM earnings -136.53